Purpose The reason for enhanced fracture healing in traumatic brain injury patients is not clearly understood. It is possible that factors inherent in the brain passing through the blood-brain barrier to the peripheral circulation, or a disruption of central nervous system (CNS) control of the sympathetic nervous system (SNS), stimulates the process of fracture healing. Methods In this study, we assessed proliferation [using the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) assay] and differentiation [using alkaline phosphatase (ALP)] in rat osteoblasts incubated with gray matter or other tissue extracts with and without the addition of an α-or β-adrenergic receptor blocker (phentolamine or propranolol). Results Gray matter extract from normal brain caused a dosedependent increase in osteoblast proliferation and differentiation. Serum from normal rats enhanced differentiation but not proliferation. Alpha-receptor blockade had no effect on proliferation or differentiation. Beta-receptor blockade caused a partial, but statistically significant, decrease in gray matter stimulation of osteoblast differentiation. Conclusion The results of this study indicate that gray matter extract from normal brain increases osteoblast proliferation and differentiation and that β receptors may be involved in differentiation under these conditions.
Introduction
Accelerated fracture healing occurs in a significant percentage of patients with traumatic brain injury [1] [2] [3] [4] [5] [6] [7] . Heterotopic ossification in the connective tissue around joints is sometimes also seen [8] [9] [10] . Though different hypotheses have been reported, a common unified explanation for this phenomenon has not been documented [7, [11] [12] [13] [14] [15] . One view is that traumatic brain injury allows growth factors that promote bone growth to pass from the brain into the systemic circulation. Another view is that altered hypothalamic mediation of sympathetic output is responsible. Alphaand β-adrenergic receptors found on human bone cells are considered to be involved in this type of regulation [16] . This research began with two hypotheses: (1) factors inherent to the brain pass through the blood-brain barrier into the peripheral circulation after brain injury to stimulate fracture healing, and (2) α-or β-adrenergic receptors are involved this stimulation. In our study, fluids extracted from different portions of the rat brain were used to stimulate osteoblast proliferation and differentiation in vitro. In addition, α 1 -and β 2 -adrenergic receptor inhibition of gray-matter extractstimulated osteoblast proliferation and differentiation was examined.
Materials and methods

Tissue preparation
Four pentobarbital-anaesthetised adult Sprague-Dawley rats were sacrificed and the following tissues obtained: total brain, gray matter, frontal and fastigial lobe white matter, pituitary, skeletal muscle, liver and blood. Serum was separated from blood cells by centrifugation (1,000 rpm, ten minutes) at 4°C. The other tissues were cut into small pieces, homogenised, diluted 1:5 (w/v) with phosphate-buffered saline (PBS), centrifuged (1,000 rpm, ten minutes) at 4°C and the supernatants used for osteoblast incubation. Chemicals, exceptions noted, were from Sigma Aldrich (USA).
Incubation protocols
For the gray matter dose-response assay, gray matter supernatants were diluted 10, 100 and 1,000 times with 10% multichannel system modified Eagle's medium (MCS-MEM) culture (MCS, Heraeus 5060, Germany; MEM, Gibco, USA). Osteoblasts were assayed for alkaline phosphatase (ALP) and 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) after six days of culture. To compare the effects of serum and different tissues, tissue extracts (brain, gray matter, white matter, pituitary, muscle, liver) and serum were diluted 100 times with 10% MCS-MEM culture, and osteoblasts were assayed for ALP and MTT after six days of culture. To study the effects of α 1 -and β 2 -adrenergic receptor antagonists, 100-fold dilutions of gray matter in 10% MCS-MEM culture medium with and without the addition of 1 μM propranolol hydrochloride or phentolamine hydrochloride were used. Assays for MTT and ALP were performed on days one, four and seven.
Osteoblast cell culture
Two sacrificed newborn Sprague-Dawley rats (<24 hours old) were soaked in 70% alcohol for ten minutes, and cranial bone was dissected and cut into 1-mm pieces. The pieces were digested with 0.25% trypsin for 20 minutes and agitated twice in 0.1% collagenase II for one hour. Cells were then collected by centrifugation (1,000 rpm, ten minutes) at 4°C, placed in 10% MCS-MEM, counted and cultivated in 5% carbon dioxide (CO 2 ) at 37°C. In the gray-matter dose-response experiment, four 96-well culture dishes (NUNC, Denmark) were prepared: one for control osteoblast culture and the other three for osteoblast culture in medium containing 10-, 100-or 1,000-fold dilutions of gray-matter extract. To compare serum and tissue extracts, eight 96-well culture dishes were prepared: one for control and the others for osteoblast cultures in which medium was supplemented with serum or one of the seven tissue extracts. To study the effects of α 1 -and β2-adrenergic receptor antagonists, 100-fold dilutions of gray matter in 10% MCS-MEM culture, with and without the addition of 1 μM propranolol or phentolamine, were used. After an initial 24-hour incubation, the culture media was changed every two to three days, depending on the assay. In proliferation assays, cells were digested with 0.25% trypsin when they had become nearly confluent and had undergone two passages.
Osteoblast identification
Passage-two cells were inoculated into culture dishes and spread on sterile glass slides. When cells became confluent, the slides were removed, and the cells were rinsed with PBS and fixed with 0.25% glutaraldehyde for ten minutes. Photographs were taken under a light microscope (40x magnification, Nikon E600, Japan) after Alcian blue staining.
Osteoblast proliferation
Osteoblast proliferation was measured using the MTT assay, which records mitochondrial metabolism. In this assay, MTT is oxidised to indigo crystals by succinate dehydrogenase produced by the mitochondrion during energy metabolism. Crystals are deposited on and in the cells in direct proportion to the number of viable cells, thus providing an estimate of cell proliferation. For this assay, passage-two osteoblasts were inoculated in 96-well culture dishes 1×10 3 cells per well, eight wells per dilution. After day two, supplemented medium was changed every three days using 0.25 ml per well. On day eight, culture dishes were rinsed with PBS, and 100 μl of MEM and 10 μl MTT (5 mg/ml) per well were added. After incubation at 5% CO 2 at 37°C for four hours, 20% sodium dodecyl sulphate (SDS), 50% Ndimethylformamide and 2% glacial acetic acid was added, and cells were incubated two hours at 37°C. The crystalviolet stains that formed were analysed photometrically using a microplate reader at a wavelength of 570 nm.
Osteoblast differentiation ALP activity, a biomarker for osteoblast differentiation, was determined by measuring the conversion of p-nitrophenyl phosphate to p-nitrophenol [17] . Passage-two osteoblasts were inoculated in 96-well culture dishes, 1×10 3 cells per well, eight wells per determination. After day two, fluid was changed with supplemented medium every three days using 0.25 ml per well. On day eight, culture dishes were rinsed with PBS and 100 μl of 50 mmol/L diethanolamine [including 20 mmol/L magnesium (Mg ++ ), pH 10.5], and 50 μl of 3 mmol/L paranitrophenol phosphate was added. Subsequently, 50 μl of 0.2 mmol/L natrium hydroxydatum was added for a further 30 minutes at 37°C. ALP activity for each well was determined at 405 nm (ELX-800, USA).
Statistical analysis
Data are presented as mean±standard deviation (SD) and tested with analysis of variance (ANOVA); dose-dependent effects were adjusted with Tukey's method; ALP and MTT syntheses were adjusted with Dunnett's method. Data were analysed using SPSS 15.0 (SPSS, Inc., Chicago, IL, USA). A P value<0.05 was considered significant.
Results
Dose-dependent effect of gray-matter extracts on proliferation and differentiation Gray-matter extracts increased osteoblast proliferation in a dose-dependent manner. As shown in Fig. 1, 10 -fold and 100-fold, but not 1,000-fold gray matter dilutions significantly increased proliferation over control values (P<0.05). Gray-matter extracts also increased osteoblast differentiation in a dose-dependent manner. All three dilutions caused a statistically significant increase in differentiation compared with control.
Based on these results, 100-fold dilutions were used for tissue-extract experiments.
Effects of tissue extracts on proliferation Total brain, gray-matter, and white-matter extracts significantly increased osteoblast proliferation compared with control (Fig. 2, P<0 .05). Osteoblast proliferation in response to pituitary, hepatic and muscle extracts and serum was similar to control values. These results suggest that normal gray and white matter contain factors that might be released into the peripheral circulation in traumatic brain injury to increase bone formation and fracture healing.
Effects of tissue extracts on synthesis of ALP, the biomarker for osteoblast differentiation Serum and both gray-and white-matter extracts significantly increased osteoblast ALP synthesis compared with control (Fig. 3, P<0 .05). Total brain extract and extracts of the other three tissues showed no effect. Gray matter had the most pronounced effect and caused a 310% increase in ALP synthesis over control (P<0.01).
Effects of tissue extracts on ALP/MTT ratio
Gray-and white-matter extracts significantly increased osteoblast proliferation and differentiation (Figs. 2 and 3) . The increased differentiation could be a direct effect or because the increased proliferation led to a more rapidly confluent monolayer and hence an earlier start on the differentiation pathway. To answer this question, we calculated the ALP/MTT ratio in order to estimate the change in ALP expression per osteoblast; that is, the direct Values in the graphs are mean±standard deviation (SD) and were obtained from eight replicates. *P<0.05 compared with control Fig. 3 Effect of brain and other tissue extracts on osteoblast differentiation. Osteoblasts were assayed for ALP after 6 days of culture. Values in the graphs are mean±standard deviation (SD) and were obtained from eight replicates. *P<0.05 compared with control. ALP alkaline phosphatase effect of the extract on osteoblast differentiation. Gray-matter, white-matter and pituitary extract, and serum significantly increased osteoblast ALP/MTT ratio over control, with gray matter having the most pronounced effect (Fig. 4, P<0.05) . Extracts of total brain, muscle and liver did not significantly change ALP/MTT ratio.
Effects of α-and β-adrenergic receptor inhibition on proliferation Proliferation increased with time in all groups, being highest on day seven. Osteoblasts incubated with graymatter extract showed significantly higher proliferation than control at all time points. Adrenergic-receptor inhibition, whether α 1 or β 2 , had no effect on proliferation. (Fig. 5) Effects of α-and β-adrenergic receptor inhibition on differentiation Osteoblast differentiation showed virtually no increase until day seven, when it increased substantially in all cell groups. The increase on day seven was significantly lessened by incubation with a β-adrenergic receptor blocker compared with gray-matter incubation alone. Alpha-adrenergic receptor blockade had no effect. (Fig. 6) 
Effects of α-and β-adrenergic inhibition on ALP/MTT ratio
The ALP/MTT ratio, the indicator of the fraction of differentiated osteoblasts, decreased in all four groups on day four, when proliferation had begun but differentiation had not yet started. By day seven, when differentiation had begun, the fraction of osteoblasts that were differentiated increased in all groups. However, cells incubated with propranolol had a significantly smaller fraction of differentiated osteoblasts than osteoblasts cultured with gray matter alone or with the alpha receptor blocker. (Fig. 7) 
Discussion
Major outcomes
In this study, gray-matter extracts from the brain of normal rats induced both proliferation and differentiation of rat osteoblasts. Serum from normal rats induced osteoblast differentiation but not proliferation. When α 1 -or β 2 -adrenergic antagonists were added to a gray-matter extract/osteoblast incubation, neither antagonist affected osteoblast proliferation. However, the β antagonist caused a significant decrease in gray-matter-stimulated osteoblast differentiation.
Effects of normal brain and tissue extracts on osteoblast proliferation and differentiation
In this study, we postulated that normal rat brain contained substances that might be released into the circulation as a result of traumatic brain injury and accelerate fracture healing. Whole-brain, gray-matter, and white-matter extracts increased osteoblast proliferation. Gray-and white-matter extracts but not whole-brain extracts increased osteoblast differentiation, and the most profound effect, in both assays, was caused by gray-matter extract. None of the other tissue extracts had any effect on proliferation, but pituitary extract and serum caused a significant increase in differentiation. These results support the hypothesis.
CNS/humoral pathway to accelerated fracture healing Enhanced fracture healing and heterotopic ossification in traumatic brain injury patients have been reported by many authors [2] [3] [4] [5] [6] [7] [8] [9] [10] 18] . The most widely investigated hypothesis is that breakdown of the blood/brain barrier after trauma allows factors that promote osteoblast growth and maturation to be released into the circulation and cause accelerated fracture healing [7, 15, [19] [20] [21] [22] [23] Mitogenic effect of serum from individuals with traumatic brain injury Experiments to investigate the possibility that mitogenic factors passing through the blood-brain barrier cause increased fracture healing have focused mainly on the mitogenic action of serum on cultured cells. Serum from patients or animals with traumatic brain injury has been shown to have osteogenic activity and a greater mitogenic activity than serum from nonbrain-injured subjects [7, 15, 19, 20, 22, 23] . Mitogenic activity apparently comes from brain tissue itself, for cerebrospinal fluid (CSF) from traumatic brain injury patients is able to increase osteoblast proliferation [15, 21] . Inflammatory or other products generated by brain cells in response to injury might be the source of the mitogenic activity seen in serum. However, primary cortical cells cocultured with osteoblasts increase osteoblast proliferation [24] . In our study, extracts of normal rat brain also increase osteoblast proliferation. Therefore, normal brain constituents, in the absence of inflammation or injury, have an ability to increase mitogenesis.
Possible mitogens
Traumatic brain injury serum contains proteins not found in normal serum that binds to the osteoblast cell surface [20] . A number of possible growth-promoting substances, including bone morphogenetic proteins, have been investigated as possible serum factors responsible for accelerated fracture healing [15, 21, [25] [26] [27] , but no definitive results have yet emerged.
Osteoblast differentiation
Our research showed that gray-and white-matter extracts from normal rat brain increased osteoblast differentiation directly, in addition to any indirect effect resulting from the increased proliferation. This double proliferation-differentiation effect is more difficult to interpret mechanistically, because osteoblast proliferation has been shown to occur first, stop, and be followed by increased differentiation [28] . However, in our study, an effect on differentiation was not always linked to proliferation. Serum from traumatic brain injury patients increases both osteoblast proliferation and differentiation [15] . Both proliferation and differentiation occur when osteoblasts are cocultured with primary cortical cells [24] . Neither of these studies addressed the question of whether the differentiation seen was a direct effect or a result of increased proliferation. Possible SNS involvement in accelerated fracture healing Our second hypothesis was that the SNS was involved in traumatic brain-injury-induced acceleration of fracture healing. The CNS normally exerts a restraining influence on bone formation. Leptin binding in the hypothalamus increases sympathetic output, and the subsequent increased beta-adrenergic tone inhibits osteogenesis [29] . Osteoblasts and osteoclasts do not synthesise catecholamines, and catecholamines regulating these cells are derived from neuronal cells or the circulation [30] . It has been suggested that brain trauma causes removal of normal CNS restraint and expedites fracture healing [19, [30] [31] [32] . We found no effect of α-and β-antagonists on gray-matter-induced osteoblast proliferation, and a partial, but statistically significant, effect of the β-antagonist in inhibiting osteoblast differentiation. The β 2 -adrenergic receptor can be expressed in osteoblasts of humans and rats. Although evidence demonstrates the expression of β 2 -adrenergic receptors in osteoblasts, the effect of other adrenergic receptors cannot be excluded. Adrenaline has been shown to promote osteoblast proliferation and ALP synthesis through the α 1 -receptor [33] . In addition, Aitken et al., in 2009, reported that β 2 -adrenergic receptor stimulation had no effect on osteoblast proliferation and differentiation [30] .
Study limitations
First, the 100-fold dilutions of the extracts may be not the best choice for osteoblast culture. If we had used more than three dilutions in our initial experiment with gray matter, we might have found a better dilution choice. To determine whether the increased osteoblast differentiation was caused by proliferation or was a direct action of the extract on differentiation, we calculated the value of ALP divided by MTT to evaluate the amount of direct differentiation enhancement. Because the two values were not from the same sample, it is possible that sample error occurred. Additional work is needed to investigate the detailed gene profile of CNS factors causing the increased and possible involvement of damage to CNS regulation of the SNS [34] .
